Qube Research & Technologies (QRT)’s PAVmed PAVM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Hold
0
-$1 4636
2023
Q3
Hold
0
4042
2022
Q4
Sell
-127
Closed -$49K 2860
2022
Q3
$49K Sell
127
-15
-11% -$8.5K ﹤0.01% 2139
2022
Q2
$60K Buy
+142
New +$68.6K ﹤0.01% 2087
2022
Q1
Sell
-215
Closed -$237K 2851
2021
Q4
$237K Buy
215
+158
+277% +$343K ﹤0.01% 1902
2021
Q3
$219K Buy
57
+6
+12% +$18.9K ﹤0.01% 1621
2021
Q2
$146K Buy
+51
New +$120K ﹤0.01% 1869

Other funds holding PAVM

Qube Research & Technologies (QRT)'s PAVM Position: Q4 2023 in Review

Qube Research & Technologies (QRT) held its PAVmed (PAVM) position steady in Q4 2023 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #4636.

Qube Research & Technologies (QRT) first reported a position in PAVM in Q2 2021 and has held it in 5 quarters since. The position peaked at $237K in Q4 2021. 23 funds tracked by Wall St. Rank hold PAVM as of Q4 2023.

  • Qube Research & Technologies (QRT) held 0 shares of PAVmed worth $0 as of Q4 2023.
  • Qube Research & Technologies (QRT) left its PAVmed share count unchanged in Q4 2023.
  • PAVmed made up ﹤0.01% of Qube Research & Technologies (QRT)'s portfolio in Q4 2023, its #4636 holding.
  • Qube Research & Technologies (QRT) first reported a position in PAVmed in Q2 2021 and has held it in 5 quarters since.
  • Qube Research & Technologies (QRT)'s PAVmed position peaked at $237K in Q4 2021.
  • 23 funds tracked by Wall St. Rank held PAVmed as of Q4 2023.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q4 2023, filed 13 Feb 2024.